Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023418 (leukemia)
 93,477 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

104 patients with various cancer, excluding malignant lymphoma and leukemia, underwent bone marrow biopsy using a Jamshidi needle, regular type. In 100 patients an adequate pice of bone marrow was obtained. In 24 patients metastases were detected in the bone marrow. Metastases were found in 10 of 38 (26.3%) patients with breast cancer, in 5 of 17 (29.4%) patients with lung cancer, in 5 of 10 (50%) patients with cancer of the prostate, in 1 patient with rhabdomyosarcoma, 1 with chordoma and in 2 of 14 patients who underwent biopsy in search of unknown cancer. 71% of the patients with positive findings in the bone marrow had clinical signs of bone involvement, 80% had positive X-ray film and 78.9% had positive skeletal isotope survey. Hemogram, serum alkaline phosphatase, serum calcium level and sedimentation rate were of no value in predicting whether the marrow was involved or not. No complications were documented following biopsy. The use of the Jamshidi bone marrow biopsy needle for staging and early detection of metastases in a select group cancer patients is suggested.
 ...
PMID:Bone marrow biopsy in patients with malignant neoplasms other than lymphomas or leukemia. 11 9

Usnic acid, a lichen antibiotic, showed low-level activity in the Lewis lung carcinoma test system. In an effort to produce new agents of potential use in the treatment of lung cancer, derivatives of the natural product were synthesized and evaluated with a cytotoxicity assay. Structure--activity analysis of the cytotoxicity data indicated the importance of the lipophilicity and the beta-triketone moiety of usnic acid on cytotoxicity. No significant increases in survival of test animals over controls were shown by any of the synthetic compounds in the P388 leukemia or the Lewis lung carcinoma test systems.
 ...
PMID:Usnic acid derivatives as potential antineoplastic agents. 16 Apr 61

The new semisynthetic epipodophyllotoxin VP 16-213 has been tested for antitumor activity and toxicity in a non-randomized phase II trial. The study included 33 patients with solid tumors and acute leukemias. The drug was given in 5-day courses every 3 weeks, parenterally for the first 2 courses and thereafter orally. Subjectively VP 16-213 was well tolerated in both i.v. and oral administration, but almost universally induced leukothrombopenia and hair loss. The best results were achieved in 12 patients with oat cell carcinoma of the lung (4 good and 4 less good responses). Remissions of lesser quality were also observed in anaplastic lung cancer, ovarian carcinoma and acute myelomonocytic leukemia. VP 16-213 possesses proven, clinically valuable cytostatic activity against various human neoplasms. Complementary studies to establish its optimum dosage and administration, and its place in combination chemotherapy, are in progress.
 ...
PMID:[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors]. 17 37

Isolation of the Epstein-Barr virus (EBV) in suspension lymphoblastoid cell lines from human patients with tumor diseases, mainly malignant lymphoma, has been described. It has been shown that the EBV was isolated from human patients with myeloid type of leukemia in 75% of cases. A similar virus was also isolated from patients with Hodgkin's disease and leukemoid reaction of the myeloid type for lung cancer. Morphological, cytochemical, immunological, and cytogenetic characteristics of the cell lines in which the EBV is replicated have been investigated.
 ...
PMID:The establishment of the suspension Epstein-Barr virus producing cell lines from patients with tumoral diseases. 22 67

The cytogenetic control of 17 mouse tumor cell strains from of the collection of the bank of the Centre for Oncology Research of the AMS USSR was made: 4 leukemias (L-5178Y, L-1210, L-1210 resistant to 6-mercaptopurine, P-388), 2 sarcomas (S-180, S-298), 8 carcinomas (Ehrlich ascitic carcinoma, carcinoma 755,6-mercaptopurine resistant carcinoma 755, lung cancer LC-67, cervical cancer CC-2, cervical cancer CC-5, stomach cancer GC-5), 2 melanomas (B16, S91) and 1 plasmocytoma (MOPC 21). A comparison of their cytogenetic features allowed a conclusion to be drawn on the absence of any contamination among 14 strains of this collection. Carcinoma 755, sarcoma 298 and leukemia L-5178Y need some further examination for such inference to be valid.
 ...
PMID:[Cytogenetic characteristics of transplantable mouse tumors]. 29 90

There is much experimental data which indicates that ionizing radiation is a very potent carcinogenic agent. Most types of carcinoma can be produced by radiation. Carcinoma is apparently induced through a single or a series of mutations in somatic cells. Radiologists have excess leukemia and other malignancy from external x-ray; uranium and other miners have excess lung cancer from internal alpha radiation; luminous dial painters have excess osteogenic sarcomas; and uranium mill workers appear to have excess lymphomas. A large number of persons are now exposed occupationally to radiation from nuclear reactors, and from various uses of radioisotopes. For the induction of most types of cancers from radiation it appears that the risk is between 0.5 and 2 cancers per rem per million person years. Epidemiological techniques are essential in determining risks of this low magnitude. Other agents may inhibit or enhance the carcinogenicity of radiation.
 ...
PMID:Occupational exposure to radiation as a cancer hazard. 32 45

Sera from 134 selected patients with various types of cancer were tested for soluble antigen-antibody complexes by the C1q binding method. Sera from 85 healthy blood bank donors served as normal controls. C1q binding activity (C1q BA) values above the 95th percentile for healthy subjects were found in 83% of sera from patients with neoplastic diseases. The incidence of abnormal C1q BA values among patients with malignant melanoma was 83%, with breast cancer 74%, with colon cancer 75%, with lung cancer 88%, with leukemia and lymphoma 85%, and with miscellaneous tumors 94%. High C1q BA values were found most frequently in sera of patients who had been diagnosed relatively recently (within 5 mo) and who had evident residual disease after surgical treatment. Recurrence or progression of tumor growth occurred significantly more frequently in lung cancer patients with high C1q BA. DNA was not detected in cancer patients' sera and treatment with DNase did not decrease in C1q BA. C1q BA in sera could not be explained by the presence of antiglobulin antibodies. Sucrose density gradient ultracentrifugation studies of the serum C1q BA in 4 cancer patients showed that the major binding activity was found between 19S and 7S.
 ...
PMID:The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. 32 5

The risk factors for radiation induced cancer (no dose threshold) given by UNSCEAR and ICRP are discussed. Under the (uncertain) supposition of the validity of these values for the roentgendiagnostic the number of cases induced by the mass screenings (VRRU) are estimated (lung and breast cancer, leukaemia). For 30 radiophotofluorographs of the thorax per person during the whole life there may be induced about 180 cancer of the lung, 5 of the breast and 27 leukaemias each year. These numbers are compared with the cases per year of lung tuberculosis and lung cancer found by VRRU. The connection between the cases of cancer and the irradiation cannot be validated statistically.
 ...
PMID:[On the problem of radiation damage caused by roentgenography of the thorax (author's transl)]. 43 28

Patterns, change in occurrence, causative risk factors, and control strategy for cancer of each site in Japanese populations were studied by applying standard methods and techniques of biostatistics and epidemiology. As the results, cancers in Japan were classified into two groups: one on the decrease (stomach, cervix) and the other on the increase (lung, colon, pancreas, breast, prostate, urinary organs, leukemia). Analysis of vital statistics, national nutrition survey data, and on-going prospective study data revealed change in selective dietary intake and increase in cigarette consumption are the major factors responsible for such trend. Epidemiological characteristics and major risk factors of cancers of stomach, colon, pancreas, lung, breast, uterine cervix, ovary, endometrium, prostate, urinary bladder, and leukemia in Japan were summarized. A limited effect of mass screening was observed in the case of stomach cancer in addition to the strong effect of diet and nutrition. Cigarette smoking was confirmed to be the major causative factor of lung cancer in Japan. A close association of increased intake of animal fat and breast cancer risk in Japanese women was also observed.
 ...
PMID:Cancer epidemiology in Japan. 54 May 84

An increased mortality from lung cancer, cardiovascular disease, haematolymphatic malignancy and cirrhosis of the liver has been reported among smelter workers and others exposed to arsenic. This study uses the case-referent (case-control) technique and is concerned with workers in a copper smelter in a complex work environment, characterised by the presence of trivalent arsenic in combination with sulphur dioxide and copper, and also with other agents. Lung cancer mortality was found to be increased about five-fold and cardiovascular disease about two-fold, showing a dose-response relationship to arsenic exposure. Mortality from malignant blood disease (leukaemia and myeloma) and cirrhosis of the liver was also slightly increased. This mortality pattern among the smelter workers is consistent with earlier reports. An increased mortality from cardiovascular disease in this type of industry is of particular interest as it has been reported only once before.
 ...
PMID:Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. 62 94


1 2 3 4 5 6 7 8 9 10 Next >>